West Pharmaceutical Services (WST) Receivables - Other (2017 - 2026)

West Pharmaceutical Services' Receivables - Other history runs 10 years deep, the most recent figure standing at $15.4 million for Q1 2026.

• In Q1 2026, Receivables - Other fell 40.31% year-over-year to $15.4 million; the TTM figure through Mar 2026 stood at $15.4 million (down 40.31% YoY), while the FY2025 annual figure was $11.9 million, down 48.93% from the prior year.
• Receivables - Other came in at $15.4 million for Q1 2026 at West Pharmaceutical Services, up from $11.9 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $42.3 million in Q3 2024 to a low of $11.9 million in Q4 2025.
• A 5-year average of $21.4 million and a median of $19.9 million in 2023 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other surged 112.56% in 2024 and plunged 48.93% in 2025, its largest moves.
• West Pharmaceutical Services' Receivables - Other stood at $16.3 million in 2022, then surged by 31.9% to $21.5 million in 2023, then advanced by 8.37% to $23.3 million in 2024, then slumped by 48.93% to $11.9 million in 2025, then climbed by 29.41% to $15.4 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $15.4 million, $11.9 million, and $27.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison